NCT06295653

Brief Summary

The objective of this study will be to assess the efficacy of the peri-implant mucosal thickness enhancement following either subepithelial connective tissue grafts or Amnion Chorion Membrane placed simultaneously with dental implant placement.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
26

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 21, 2023

Completed
5 months until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 6, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2025

Completed
Last Updated

March 6, 2024

Status Verified

March 1, 2024

Enrollment Period

2 months

First QC Date

September 21, 2023

Last Update Submit

March 3, 2024

Conditions

Keywords

dental implantSubepithelial Connective Tissue GraftAmniotic Chorion Membranefor Peri-implant Mucosa

Outcome Measures

Primary Outcomes (1)

  • measure changes in periimplant mucosal thickness

    The primary outcome of interest will be to measure changes (in mm) in horizontal periimplant mucosal thicknesson the buccal aspect of the edentulous alveolar ridge from baseline (BL) (implant placement and grafting) to (3 and 6 month) of post-surgical healing.

    six months

Secondary Outcomes (1)

  • mid-buccal keratinized mucosal width

    six month

Study Arms (2)

Autogenous Subepithelial Connective Tissue Graft plus dental implants

ACTIVE COMPARATOR

implant placement and augment Subepithelial Connective Tissue Graft and suture implant site

Procedure: implant placement and soft tissue augmentation with Autogenous Subepithelial Connective Tissue Graft or Amniotic Chorion Membrane

Amniotic Chorion Membrane plus dental implant

ACTIVE COMPARATOR

implant placement and augment Amniotic Chorion Membrane and suture implant site

Procedure: implant placement and soft tissue augmentation with Autogenous Subepithelial Connective Tissue Graft or Amniotic Chorion Membrane

Interventions

assess the efficacy of the peri-implant mucosal thickness enhancement following either subepithelial connective tissue grafts or Amniotic Chorion Membrane placed simultaneously with dental implant placement.

Also known as: measure mucosal thickness with probe, connective tissue grafting from palate
Amniotic Chorion Membrane plus dental implantAutogenous Subepithelial Connective Tissue Graft plus dental implants

Eligibility Criteria

Age30 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with good systemic health with no contraindication for periodontal surgery.
  • No history of any medications in the previous 6 months that may interfere with periodontal tissue health or healing.
  • Ability to maintain good oral hygiene as evidenced in recall visits.
  • Aged 30 to 55 years.
  • Stable periodontal condition and missing one single tooth (maxillary anterior teeth and premolars) with adjacent teeth present and thin mucosal phenotype (\< 2mm bucco- lingual thickness).

You may not qualify if:

  • Medically compromised patients and systemic conditions precluding periodontal surgery.
  • Smokers.
  • Severe hematologic disorders (e.g., hemophilia or leukemia), uncontrolled infectious or metabolic diseases that could compromise normal healing, liver, or kidney dysfunction/failure.
  • Patients subjected to irradiation in the head and neck area.
  • Patients treated or under treatment with intravenous amino bisphosphonates.
  • Patient affected by active periodontitis or has poor oral hygiene and motivation.
  • Uncontrolled diabetes mellitus.
  • Pregnant women or planning become pregnant, and nursing mothers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculity of Dentistry Tanta University

Tanta, Elgarbia, 6620012, Egypt

Location

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of Oral Medicine, Periodontology, Oral Diagnosis & Radiology

Study Record Dates

First Submitted

September 21, 2023

First Posted

March 6, 2024

Study Start

March 1, 2024

Primary Completion

April 30, 2024

Study Completion

April 30, 2025

Last Updated

March 6, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will share

share the results to determine the difference between the materials used in the research and the possibility of using the best ones

Shared Documents
SAP
Time Frame
at the end of the research When the data are available

Locations